
|Articles|May 27, 2020
ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye
Author(s)Alex Delaney-Gesing
Advertisement
Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
4
REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy
5
























